Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Then you are saying the ceo of pfizer can go to his board and justify offering 20,000% premium for a buyout. Can you list 5 companies that were bought for more than 200% premium? You don't understand any of my points nor how businesses operate. There will be no buyout anytime soon because the MC is too low. You can make all the logical points you want, but nothing is going to change the facts I listed.
He did not leave in frustration. It is obvious he left at this time because a major goal has been accomplished. He probably wanted to leave much sooner but Nasrat probably asked him to stay until after the new year. The application has been filed and probably accepted. It's a perfect time for a vip to leave. He probably unofficially left before Christmas break.
Why do you think it will be unsuccessful?
yep, but not for Elite Longs.
By your own words you agreed with what I stated.
That is not a material event, and he has already said that he is not going to report the submission, only the acceptance.
Per yahoo statistics, there are 4M OS and 1.77 float. Many stocks that go parabolics trade well beyond the OS in a day.
In that case, I'm going to go sell all of my shares right now.
Anybody have legitimate thoughts on what the goal is for such heavy shorting? We ALL know the company is legitimate and not going to fail, so they aren't shorting because they expect the company or stock to fall naturally. The stock price only drops because they are manipulating it to drop. Are they shorting just for small gains? Is it related to a company who plans to buy ELTP and just wants to keep price as low as possible? doesn't seem likely. Is it something else?
please tell us more.
There is no way to put a positive spin on it. I applaud your effort, but it is futile.
It typically means Claytrader has posted a link to his chart review.
I think you are referring to the 100K shs of the stock listed after ELTP
You are wrong. It's 25K. You have to download the full form to see how many shares.
Most likely will be August 2016 but we won't receive revenues until 2017.
The harder you protest this stock, the more confidence I have in it.
What part of "Dart can't dump shares" do you not understand? The vast majority of new shares will go to Dart. HE CAN'T DUMP THEM. Is that clear enough?
Far more results come out negative than positive. More endpoints are missed than hit. I have no doubt Elite will be fine with their results, but the whole point of the "top-line" results has been missed. "Top-line" refers to quality of a study and not quality of results of a study.
I've been in several companies that announced negative top-line results. I'm confident I never said anything about Nasrat touting negatives results. I pointed out that Nasrat's pr was neither positive nor negative. Some of you don't understand what "top-line" means.
Top-line does not inherently mean positive. Top-line can be negative, can it not?
That hasn't helped any in the past year.
Maybe you should look at the difference in share count and also the pump job that was done to shoot that up.
You will have to wait a lot longer than 6 months for the FDA to approve it. 4-5 months for submission. 5-6 months for approval. Then delivering the product. Then have to wait a while to receive payments. Probably well over a year before we get money for first shipments. Depressing.
Are you no longer expecting p2 results out soon?
Either way, we don't seem to be in any technical breakout area, and we certainly had no legitimate chance at .77 yesterday or today.
What p2? They haven't even started p2.
I don't believe you
He didn't say anything. All he said was that it may go up or it may go down. How is that helpful? Basically all numbers are in play. I know that without looking at a chart.
AVXL is different. Hopefully, we'll do like they have instead of the other way around. AVXL popped in April, faded down, then slowly climbed back up, finally exploding the last 2 days.
Hopefully, we will climbed back up and then exploded again.
What does the sale of Novel/Gavis say about the potential value of our own generics?
Nasrat locked himself in much higher than that "best case scenario" valuation last year. No way he could back track and say the company is less valuable than 3.5 to 4 pps. All the details of that valuation would be exposed in court.
Do you have any proof?
If you aren't soft bashing, then show a link that verifies that many outstanding shares. There's no guarantee all those warrants will be exercised. As we can see, some have already disappeared.
There are not 101 million os for TPIV. You know it, and most of us know it. I'm sure others can tell what you are doing.
Hopefully, P2 starting sometime. Possible fast track status, Orphan status, additional P1 data, collaborations, etc.
Brilliant response. I can't refute "Ha, ha, ha."